Investors / United States / Mitsui Global Investment
Mitsui Global Investment
Corporate VC · Menlo Park, CA, United States · North America
Mitsui Global Investment is the venture investment arm of Mitsui & Co., investing in startups and guiding entrepreneurs toward the global stage. It has been operating for over 20 years, with more than 100 portfolio companies and over 35 exits including M&As, IPOs and SPAC mergers.
Invests inHealthcare & Biotech
In its own wordstechnologylife sciencescomputer visionsatellite datamediadeep tech
Your fit with Mitsui Global Investment
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsMitsui Global Investment lists 32 checked portfolio companies on its own site and is named in 8 funding rounds. Its most frequent entry is Series A, 60% of the companies with a known first round. Its largest themes are Healthcare & Biotech (36%), AI & Machine Learning (13%) and Industrial & Manufacturing (13%). 75% of its companies are based in United States. It invests most often alongside AIX Ventures, Balerion Space Ventures and Dolby Family Ventures.
Counts come from funding rounds that name Mitsui Global Investment, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Mitsui Global Investment's whole history. Rounds on record name 7 companies; its own site lists 32. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundMitsui Global Investment does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 60% |
| Series B | 20% |
| Growth | 20% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 7 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 70th | 32 companies |
| Recent activity | 91th | 7 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 57th | 3% of companies confirmed by a round |
| Sector focus | 66th | 36% in its largest sector |
| Reach | 78th | 5 countries |
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 36% | 15% |
| AI & Machine Learning | 13% | 18% |
| Industrial & Manufacturing | 13% | 7% |
| Enterprise Software | 11% | 8% |
| Mobility & Logistics | 6% | 1% |
| Climate & Energy | 4% | 1% |
| Media & Entertainment | 4% | 4% |
| Cybersecurity | 4% | 4% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| AIX Ventures | 2 |
| Balerion Space Ventures | 2 |
| Dolby Family Ventures | 2 |
| Droia Ventures | 2 |
| E12 Ventures | 2 |
| Evolution VC Partners | 2 |
| IQT | 2 |
| Lux Capital | 2 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3197%
- No longer answers00%
- Points to another company13%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherCompare Mitsui Global Investment head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Mitsui Global Investment| Date | Company | Stage |
|---|---|---|
| 31 Aug 2026 | Series A | |
| 5 Aug 2026 | Series C+ | |
| 27 May 2026 | Series A | |
| 19 May 2026 | Series B | |
| 5 Mar 2026 | Debt | |
| 5 Mar 2026 | Series A | |
| 19 Feb 2026 | Round | |
| 4 Sept 2025 | Round |
Round details for Mitsui Global Investment
Amounts, full round histories and every co-investor in Mitsui Global Investment's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
32 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Armada provides ruggedized modular data centers and edge computing hardware and software for deploying GPU infrastructure in remote and demanding environments. | Enterprise SoftwareIndustrial & Manufacturing | May 2026Series B | Funding round | |
Healthcare & Biotech | Portfolio page | |||
| ContinuumRx provides home and site-based infusion therapies and services to patients, including antibiotic therapy, enteral nutrition, and parenteral nutrition, among others. | Healthcare & Biotech | Portfolio page | ||
| The company designs and manufactures power management and wireless charging products for various applications, including consumer electronics and automotive systems. | ConsumerIndustrial & Manufacturing | Portfolio page | ||
| E Dash provides a service platform to support companies in reducing their CO2 emissions | Space & DefenseClimate & Energy | Aug 2026Series A | Funding round | |
| Ellipsis Health develops and provides an AI care manager for healthcare companies to manage patient engagement and care coordination | Healthcare & Biotech | Portfolio page | ||
| Ensem Therapeutics develops innovative small molecule precision medicines for oncology using its Kinetic Ensemble platform | Healthcare & Biotech | Portfolio page | ||
| Kaltura provides a platform for creating and managing video and AI avatar experiences for enterprises. | Media & EntertainmentEducation | Portfolio page | ||
| LanzaJet is working to meet the demands of the global aviation industry by advancing the production of Sustainable Aviation Fuel (SAF) that is compatible with existing aircraft and infrastructure. | AI & Machine LearningAI & Machine Learning | Feb 2026Round | Funding round | |
| Mahzi Therapeutics is focused on treating under-served rare genetic neurodevelopmental disorders. | Healthcare & Biotech | Portfolio page | ||
| NapaJen Pharma develops and researches bio pharmaceuticals with a focus on nucleic acid medicine delivery technology | Healthcare & Biotech | Portfolio page | ||
| The company provides virtual neurology clinic services, including video visits with board-certified neurologists and personalized treatment plans. | Healthcare & Biotech | Portfolio page | ||
| On-chip Biotechnologies develops and sells microfluidic chip-based cell sorters and dispensers for single cell analysis and high-throughput screening | Healthcare & Biotech | Portfolio page | ||
| OpenX provides a supply-side platform for programmatic advertising | Media & EntertainmentHealthcare & Biotech | Portfolio page | ||
| Pinnacle Engines develops and commercializes ultra-efficient engine architecture for various applications, including home energy, industrial and hybrid vehicles. | Industrial & ManufacturingMobility & Logistics | Portfolio page | ||
| Proterra designs and manufactures battery systems for electric vehicles and commercial equipment. | Industrial & ManufacturingMobility & Logistics | Portfolio page | ||
| QD Laser develops and manufactures laser technology products for various fields, including communication, industry, and medical care. | Healthcare & BiotechIndustrial & Manufacturing | Portfolio page | ||
| Quantinuum develops and provides quantum computers and related software solutions | Healthcare & BiotechCybersecurity | Sept 2025Round | Funding round | |
| QurAlis discovers and develops effective precision medicines for neurodegenerative and neurological diseases | Healthcare & Biotech | Portfolio page | ||
| Rallybio develops treatments for rare diseases, particularly those related to complement dysregulation and hematology. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- mitsui-global.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 4 Sept 2025
- Companies checked
- 32
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Mitsui Global Investment's profile as data
Pull Mitsui Global Investment's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/mitsui-global.com
# also
GET /v1/firms/mitsui-global.com/portfolio
GET /v1/firms/mitsui-global.com/coinvestors
GET /v1/firms/mitsui-global.com/news